SEC reporting owner

PERRY MARK W SEC insider disclosures

Explore PERRY MARK W's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-12T05:54:58.330Z

Reporting owner CIK
0001062466
Issuers
29
Coverage
verified

Inspect this reporting owner's activity

Step 1 of 3

Issuer relationships

PERRY MARK W: source evidence dated 2026-10-12T05:54:58.330Z.

Issuer
INTERCELL USA, INC.
CIK
0001125001
Tickers
IOMI
Officer
No
Director
No
What you should see

The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.

Step 2 of 3

Which issuer and transaction does this person appear in?

Match the reviewed owner identity, issuer and transaction code. Directory eligibility does not turn every filing into a strategy signal.

What you should see

Use the linked SEC receipts and company profiles to verify what became public and when.

Step 3 of 3

Browse insider directory

Use the linked SEC receipts and company profiles to verify what became public and when.

Browse insider directory
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Issuer relationships

See the complete issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Show the table · 29 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

INTERCELL USA, INC.0001125001IOMINoNo
OCCAM NETWORKS INC/DE0001108185OCNWNoNo
TARGACEPT INC0001124105TRGTNoNo
Transcept Pharmaceuticals Inc0001178711NOVC, TSPTNoNo
VONAGE HOLDINGS CORP0001272830VGNoNo
TIVO INC0001088825TIVONoYes
INNERWORKINGS INC0001350381INWKNoNo
HEMOSENSE INC0001127393HEMNoNo
ZHONE TECHNOLOGIES INC0001101680ZHNENoNo
SOURCEFIRE INC0001168195FIRENoNo
GLU MOBILE INC0001366246GLUUNoNo
AMICUS THERAPEUTICS INC0001178879FOLDNoNo
Data Domain, Inc.0001391984DDUPNoNo
Neutral Tandem Inc0001292653TNDMNoNo
PEPLIN INC0001408808PLINNoNo
ARYx Therapeutics, Inc.0001410064ARYXNoNo
SUNESIS PHARMACEUTICALS INC0001061027SNSSNoNo
PHARMOS CORP0000713275PARSNoNo
Echo Global Logistics, Inc.0001426945ECHONoNo
INHIBITEX, INC.0001274913INHXNoNo
Financial Engines, Inc.0001430592FNGNNoNo
MOTRICITY INC0001336691MOTRNoNo
BOINGO WIRELESS INC0001169988WIFINoNo
FUSION-IO, INC.0001383729FIONoNo
Groupon, Inc.0001490281GRPNNoNo
SUPERNUS PHARMACEUTICALS INC0001356576SUPNNoNo
AUDIENCE INC0001201663ADNCNoNo
HYPERION THERAPEUTICS INC0001386858HPTXNoNo
Workday, Inc.0001327811WDAYNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

Show the table · 0 rows, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.